Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 3c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• argenx SE (ARGX) PT Raised to $1,150 at Wedbush
• NVIDIA (NVDA) call put ratio 1.9 calls to 1 put with a focus on 5K contracts of October 160 puts